Showing results (121-130 of 289) with videos related to

Sort By:
Pageof 29
Journal of Perinatology : Official Journal of the California Perinatal Association|September 8, 1998
Treatment of obstructive jaundice in erythroblastosis fetalis with ursodeoxycholic acid (UDCA): a case reportE M Perez, T R Cooper, A A Moise, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
Sodium dodecyl sulfate-resistant HLA-DR "superdimer" bands are in some cases class II heterodimers bound to antibodyC Hitzel, U Grüneberg, M van Ham, et al.
European Journal of Immunology|November 1, 1982
Cross-blocking studies with monoclonal antibodies against I-A molecules of haplotypes b, d and kN Koch, G J Hämmerling, N Tada, et al.
Immunogenetics|January 1, 1983
Structural comparison of I-A antigens produced by a cloned murine T suppressor cell line with B-cell-derived I-AN Koch, B Arnold, G J Hämmerling, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 20, 2005
Suicide among Danes with multiple sclerosisH Brønnum-Hansen, E Stenager, E Nylev Stenager, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2008
Is the treatment effect of IFN-beta restored after the disappearance of neutralizing antibodies?P S Sorensen, N Koch-Henriksen, E M Flachs, et al.
European Journal of Immunology|May 1, 1986
In vivo induction of H-2K/D antigens by recombinant interferon-gammaF Momburg, N Koch, P Möller, et al.
International Immunology|November 4, 2000
Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentationC Carstens, D K Newman, H Bohlen, et al.
Journal of Applied Clinical Medical Physics|November 8, 2003
Assessment of geometrical accuracy of magnetic resonance images for radiation therapy of lung cancersN Koch, H H Liu, L E Olsson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 21, 2009
The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosisN Koch-Henriksen, P S Sorensen, K Bendtzen, et al.
Pageof 29